NHL players have taken to the court for the first time in the NHL season for the latest positive feedback device, the MRNA vaccine mechanism.
The NHL Players Association has announced that players will have the option of wearing a MRNA device as part of their helmets and gloves, in addition to wearing their team-issued protective gear.
The new system will be installed in the helmet and glove boxes on the ice during the NHL’s opening games, with the goal of preventing players from getting any infections.
A team will need to wear protective gear at all times during the season, including wearing a protective helmet.
The MRNA is a new vaccine designed to provide protection against certain types of coronavirus, and has been available since the summer of 2014.
The device, which uses a combination of antibodies from the nasal mucosa and other immune cells, is designed to be worn as a helmet or as a glove and is supposed to last three to six weeks.
It also uses an inactivated virus and a small amount of an antibody that is not normally used in vaccines.
While it was designed to protect the nasal cavity, it is also expected to help players prevent nasal infections by helping them fight the virus, which can be spread through air.
In the coming months, the NHL will be rolling out a range of other protective gear for players, including the mask, gloves, protective equipment and masks.